Search research articles
Contact Us
Filters
Showing results (1-10 of 26) with videos related to
Page
of 3
Sort By:
American Family Physician
|
March 16, 2026
Hand Injury in a Pickleball Player
Michael L Grover, Jyoti Gurung, Erwin A Kruger
The Journal of Spinal Cord Medicine
|
October 5, 2013
Comprehensive management of pressure ulcers in spinal cord injury: current concepts and future trends
Erwin A Kruger, Marilyn Pires, Yvette Ngann, et al.
Eplasty
|
August 31, 2018
The Chimeric Myo-Osseous Medial Femoral Condyle Flap for Tibial Nonunion: A Case Report
Erwin A Kruger, Oded Ben-Amotz, Shaun D Mendenhall, et al.
Plastic and Reconstructive Surgery. Global Open
|
August 23, 2021
Surgical Management of Chronic Encapsulated Abdominal Wall Seroma 8 Years after Abdominoplasty
Bryn E Morris, Danielle A Thornburg, Chad M Teven, et al.
Therapeutic Drug Monitoring
|
January 24, 2002
5'-OH-thalidomide, a metabolite of thalidomide, inhibits angiogenesis
Douglas K Price, Yuichi Ando, Erwin A Kruger, et al.
Investigational New Drugs
|
July 9, 2002
Inhibition of angiogenesis: treatment options for patients with metastatic prostate cancer
William D Figg, Erwin A Kruger, Douglas K Price, et al.
Plastic and Reconstructive Surgery. Global Open
|
September 28, 2020
Negative Pressure Wound Therapy in Malignancy: Always an Absolute Contraindication?
Lacey R Pflibsen, Salvatore C Lettieri, Erwin A Kruger, et al.
International Journal of Dermatology
|
October 30, 2021
Diffuse dermal angiomatosis of the bilateral breast successfully treated with reduction mammoplasty
Collin M Costello, Muhammad Q Qureshi, Erwin A Kruger, et al.
Advances in Skin & Wound Care
|
December 21, 2005
The role of therapeutic angiogenesis in tissue repair and regeneration
William W Li, Katherine E Talcott, Amy W Zhai, et al.
Journal of Medicinal Chemistry
|
August 22, 2003
Thalidomide metabolites and analogues. 3. Synthesis and antiangiogenic activity of the teratogenic and TNFalpha-modulatory thalidomide analogue 2-(2,6-dioxopiperidine-3-yl)phthalimidine
Frederick A Luzzio, Alexander V Mayorov, Sylvia S W Ng, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 26) with videos related to
Sort By:
Page
of 3
American Family Physician
|
March 16, 2026
Hand Injury in a Pickleball Player
Michael L Grover, Jyoti Gurung, Erwin A Kruger
The Journal of Spinal Cord Medicine
|
October 5, 2013
Comprehensive management of pressure ulcers in spinal cord injury: current concepts and future trends
Erwin A Kruger, Marilyn Pires, Yvette Ngann, et al.
Eplasty
|
August 31, 2018
The Chimeric Myo-Osseous Medial Femoral Condyle Flap for Tibial Nonunion: A Case Report
Erwin A Kruger, Oded Ben-Amotz, Shaun D Mendenhall, et al.
Plastic and Reconstructive Surgery. Global Open
|
August 23, 2021
Surgical Management of Chronic Encapsulated Abdominal Wall Seroma 8 Years after Abdominoplasty
Bryn E Morris, Danielle A Thornburg, Chad M Teven, et al.
Therapeutic Drug Monitoring
|
January 24, 2002
5'-OH-thalidomide, a metabolite of thalidomide, inhibits angiogenesis
Douglas K Price, Yuichi Ando, Erwin A Kruger, et al.
Investigational New Drugs
|
July 9, 2002
Inhibition of angiogenesis: treatment options for patients with metastatic prostate cancer
William D Figg, Erwin A Kruger, Douglas K Price, et al.
Plastic and Reconstructive Surgery. Global Open
|
September 28, 2020
Negative Pressure Wound Therapy in Malignancy: Always an Absolute Contraindication?
Lacey R Pflibsen, Salvatore C Lettieri, Erwin A Kruger, et al.
International Journal of Dermatology
|
October 30, 2021
Diffuse dermal angiomatosis of the bilateral breast successfully treated with reduction mammoplasty
Collin M Costello, Muhammad Q Qureshi, Erwin A Kruger, et al.
Advances in Skin & Wound Care
|
December 21, 2005
The role of therapeutic angiogenesis in tissue repair and regeneration
William W Li, Katherine E Talcott, Amy W Zhai, et al.
Journal of Medicinal Chemistry
|
August 22, 2003
Thalidomide metabolites and analogues. 3. Synthesis and antiangiogenic activity of the teratogenic and TNFalpha-modulatory thalidomide analogue 2-(2,6-dioxopiperidine-3-yl)phthalimidine
Frederick A Luzzio, Alexander V Mayorov, Sylvia S W Ng, et al.
Page
of 3